{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:36:43Z","timestamp":1793914603499,"version":"4.8.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T00:00:00Z","timestamp":1439856000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-015-1086-6","type":"journal-article","created":{"date-parts":[[2015,8,17]],"date-time":"2015-08-17T12:05:37Z","timestamp":1439813137000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Development of fluconazole resistance in a series of Candida parapsilosis isolates from a persistent candidemia patient with prolonged antifungal therapy"],"prefix":"10.1186","volume":"15","author":[{"given":"Li","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanrong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Chun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,18]]},"reference":[{"issue":"4","key":"1086_CR1","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1128\/CMR.00013-08","volume":"21","author":"D Trofa","year":"2008","unstructured":"Trofa D, Gacser A, Nosanchuk JD. Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev. 2008;21(4):606\u201325.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"1086_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3109\/10408410903213393","volume":"35","author":"EC Asbeck van","year":"2009","unstructured":"van Asbeck EC, Clemons KV, Stevens DA. Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility. Crit Rev Microbiol. 2009;35(4):283\u2013309.","journal-title":"Crit Rev Microbiol"},{"issue":"4","key":"1086_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.diagmicrobio.2004.03.011","volume":"49","author":"F Barchiesi","year":"2004","unstructured":"Barchiesi F, Caggiano G, Falconi DFL, Montagna MT, Barbuti S, Scalise G. Outbreak of fungemia due to Candida parapsilosis in a pediatric oncology unit. Diagn Microbiol Infect Dis. 2004;49(4):269\u201371.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"7","key":"1086_CR4","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00431-009-1109-7","volume":"169","author":"R Hernandez-Castro","year":"2010","unstructured":"Hernandez-Castro R, Arroyo-Escalante S, Carrillo-Casas EM, Moncada-Barron D, Alvarez-Verona E, Hernandez-Delgado L, et al. Outbreak of Candida parapsilosis in a neonatal intensive care unit: a health care workers source. Eur J Pediatr. 2010;169(7):783\u20137.","journal-title":"Eur J Pediatr"},{"issue":"12","key":"1086_CR5","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1128\/JCM.01130-12","volume":"50","author":"H Wang","year":"2012","unstructured":"Wang H, Xiao M, Chen SC, Kong F, Sun ZY, Liao K, et al. In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study. J Clin Microbiol. 2012;50(12):3952\u20139.","journal-title":"J Clin Microbiol"},{"issue":"7","key":"1086_CR6","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1128\/AAC.01053-05","volume":"50","author":"D Andes","year":"2006","unstructured":"Andes D, Forrest A, Lepak A, Nett J, Marchillo K, Lincoln L. Impact of antimicrobial dosing regimen on evolution of drug resistance in vivo: fluconazole and Candida albicans. Antimicrob Agents Chemother. 2006;50(7):2374\u201383.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"1086_CR7","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1128\/AAC.44.6.1578-1584.2000","volume":"44","author":"F Barchiesi","year":"2000","unstructured":"Barchiesi F, Calabrese D, Sanglard D, Falconi DFL, Caselli F, Giannini D, et al. Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750. Antimicrob Agents Chemother. 2000;44(6):1578\u201384.","journal-title":"Antimicrob Agents Chemother"},{"issue":"18","key":"1086_CR8","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1056\/NEJM199110313251803","volume":"325","author":"JR Wingard","year":"1991","unstructured":"Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med. 1991;325(18):1274\u20137.","journal-title":"N Engl J Med"},{"issue":"9","key":"1086_CR9","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1128\/AAC.37.9.1847","volume":"37","author":"JR Wingard","year":"1993","unstructured":"Wingard JR, Merz WG, Rinaldi MG, Miller CB, Karp JE, Saral R. Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrob Agents Chemother. 1993;37(9):1847\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1086_CR10","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1128\/AAC.49.2.767-769.2005","volume":"49","author":"V Moudgal","year":"2005","unstructured":"Moudgal V, Little T, Boikov D, Vazquez JA. Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis. Antimicrob Agents Chemother. 2005;49(2):767\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"1086_CR11","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1128\/AAC.01127-10","volume":"55","author":"AP Silva","year":"2011","unstructured":"Silva AP, Miranda IM, Guida A, Synnott J, Rocha R, Silva R, et al. Transcriptional profiling of azole-resistant Candida parapsilosis strains. Antimicrob Agents Chemother. 2011;55(7):3546\u201356.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1086_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S1473-3099(02)00181-0","volume":"2","author":"D Sanglard","year":"2002","unstructured":"Sanglard D, Odds FC. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis. 2002;2(2):73\u201385.","journal-title":"Lancet Infect Dis"},{"issue":"2\u20133","key":"1086_CR13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0925-4439(02)00087-X","volume":"1587","author":"J Morschhauser","year":"2002","unstructured":"Morschhauser J. The genetic basis of fluconazole resistance development in Candida albicans. Biochim Biophys Acta. 2002;1587(2\u20133):240\u20138.","journal-title":"Biochim Biophys Acta"},{"issue":"1 Suppl","key":"1086_CR14","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.amjmed.2011.11.001","volume":"125","author":"MA Pfaller","year":"2012","unstructured":"Pfaller MA. Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am J Med. 2012;125(1 Suppl):S3\u201313.","journal-title":"Am J Med"},{"issue":"11","key":"1086_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0030164","volume":"3","author":"J Morschhauser","year":"2007","unstructured":"Morschhauser J, Barker KS, Liu TT, BlaB-Warmuth J, Homayouni R, Rogers PD. The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans. PLoS Pathog. 2007;3(11), e164.","journal-title":"PLoS Pathog"},{"issue":"4","key":"1086_CR16","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/j.1365-2958.2008.06309.x","volume":"69","author":"N Dunkel","year":"2008","unstructured":"Dunkel N, Blass J, Rogers PD, Morschhauser J. Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains. Mol Microbiol. 2008;69(4):827\u201340.","journal-title":"Mol Microbiol"},{"issue":"12","key":"1086_CR17","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.1128\/AAC.00740-08","volume":"52","author":"S Schubert","year":"2008","unstructured":"Schubert S, Rogers PD, Morschhauser J. Gain-of-function mutations in the transcription factor MRR1 are responsible for overexpression of the MDR1 efflux pump in fluconazole-resistant Candida dubliniensis strains. Antimicrob Agents Chemother. 2008;52(12):4274\u201380.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"1086_CR18","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1128\/EC.3.6.1639-1652.2004","volume":"3","author":"AT Coste","year":"2004","unstructured":"Coste AT, Karababa M, Ischer F, Bille J, Sanglard D. TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. Eukaryot Cell. 2004;3(6):1639\u201352.","journal-title":"Eukaryot Cell"},{"issue":"4","key":"1086_CR19","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1534\/genetics.105.054767","volume":"172","author":"A Coste","year":"2006","unstructured":"Coste A, Turner V, Ischer F, Morschhauser J, Forche A, Selmecki A, et al. A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans. Genetics. 2006;172(4):2139\u201356.","journal-title":"Genetics"},{"issue":"6","key":"1086_CR20","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1128\/EC.3.6.1391-1397.2004","volume":"3","author":"PM Silver","year":"2004","unstructured":"Silver PM, Oliver BG, White TC. Role of Candida albicans transcription factor Upc2p in drug resistance and sterol metabolism. Eukaryot Cell. 2004;3(6):1391\u20137.","journal-title":"Eukaryot Cell"},{"issue":"7","key":"1086_CR21","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1128\/JCM.00493-08","volume":"46","author":"MA Pfaller","year":"2008","unstructured":"Pfaller MA, Chaturvedi V, Diekema DJ, Ghannoum MA, Holliday NM, Killian SB, et al. Clinical Evaluation of the Sensititre YeastOne Colorimetric Antifungal Panel for Antifungal Susceptibility Testing of the Echinocandins Anidulafungin, Caspofungin, and Micafungin. J Clin Microbiol. 2008;46(7):2155\u20139.","journal-title":"J Clin Microbiol"},{"key":"1086_CR22","unstructured":"Clinical and Laboratory Standards Institute.\u00a0Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Fourth Informational Supplement\u00a0M27-S4. CLSI, wayne, PA, USA, 2012."},{"issue":"5","key":"1086_CR23","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1128\/JCM.02151-09","volume":"48","author":"R Sabino","year":"2010","unstructured":"Sabino R, Sampaio P, Rosado L, Stevens DA, Clemons KV, Pais C. New polymorphic microsatellite markers able to distinguish among Candida parapsilosis sensu stricto isolates. J Clin Microbiol. 2010;48(5):1677\u201382.","journal-title":"J Clin Microbiol"},{"key":"1086_CR24","unstructured":"Berkow E, Manigaba K, Wanamaker E, Barker K, Caudle K, Rogers PD. Molecular Mechanisms of Multidrug Resistance in Candida parapsilosis. Poster. the 12th American Society for Microbiology (ASM) Conference,\u00a0USA, 2014."},{"issue":"7","key":"1086_CR25","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1128\/AAC.01438-06","volume":"51","author":"T Rossignol","year":"2007","unstructured":"Rossignol T, Logue ME, Reynolds K, Grenon M, Lowndes NF, Butler G. Transcriptional response of Candida parapsilosis following exposure to farnesol. Antimicrob Agents Chemother. 2007;51(7):2304\u201312.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"1086_CR26","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1093\/jac\/dks481","volume":"68","author":"C Jiang","year":"2013","unstructured":"Jiang C, Dong D, Yu B, Cai G, Wang X, Ji Y, et al. Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China. J Antimicrob Chemother. 2013;68(4):778\u201385.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"1086_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.drup.2007.04.002","volume":"10","author":"DS Perlin","year":"2007","unstructured":"Perlin DS. Resistance to echinocandin-class antifungal drugs. Drug Resist Updat. 2007;10(3):121\u201330.","journal-title":"Drug Resist Updat"},{"issue":"2","key":"1086_CR28","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1128\/AAC.04613-14","volume":"59","author":"NT Grossman","year":"2015","unstructured":"Grossman NT, Pham CD, Cleveland AA, Lockhart SR. Molecular Mechanisms of Fluconazole Resistance in Candida parapsilosis Isolates from a U.S. Surveillance System. Antimicrob Agents Chemother. 2015;59(2):1030\u20137.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"1086_CR29","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1128\/AAC.00019-12","volume":"56","author":"DN Shah","year":"2012","unstructured":"Shah DN, Yau R, Lasco TM, Weston J, Salazar M, Palmer HR, et al. Impact of prior inappropriate fluconazole dosing on isolation of fluconazole-nonsusceptible Candida species in hospitalized patients with candidemia. Antimicrob Agents Chemother. 2012;56(6):3239\u201343.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1086_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1128\/AAC.00705-08","volume":"53","author":"D Andes","year":"2009","unstructured":"Andes D, Pascual A, Marchetti O. Antifungal therapeutic drug monitoring: established and emerging indications. Antimicrob Agents Chemother. 2009;53(1):24\u201334.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"1086_CR31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1086\/380796","volume":"38","author":"PG Pappas","year":"2004","unstructured":"Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE. Guidelines for Treatment of Candidiasis. Clin Infect Dis. 2004;38(2):161\u201389.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"1086_CR32","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1128\/JCM.02122-07","volume":"46","author":"MA Pfaller","year":"2008","unstructured":"Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Ng KP, Colombo A, et al. Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005. J Clin Microbiol. 2008;46(3):842\u20139.","journal-title":"J Clin Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1086-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-015-1086-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1086-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,11]],"date-time":"2016-10-11T14:59:21Z","timestamp":1476197961000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-015-1086-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,18]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1086"],"URL":"https:\/\/doi.org\/10.1186\/s12879-015-1086-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,18]]},"article-number":"340"}}